Please ensure Javascript is enabled for purposes of website accessibility
Home / Opinion Digests / Business Law / No Patent Term Extension for Drug Company (access required)

No Patent Term Extension for Drug Company (access required)

In this Administrative Procedure Act case, the Alexandria U.S. District Court upholds defendant Patent and Trademark Office’s de­nial of a patent term extension for plaintiff pharmaceutical company’s ‘447 patent. In addition to holding the rights to the ‘447 patent, plaintiff also manufactures the ZILVER PTX Drug Eluting Peripheral Stent (Zilver PTX), a medical device that physical­ly ...

Leave a Reply